KPV Tripeptide Demonstrates Therapeutic Benefits Against Colitis-Associated Cancer in Murine Models | RemedyX Labs Research Library

A research summary of Critical Role of PepT1 in Promoting Colitis-Associated Cancer and Therapeutic Benefits of the Anti-inflammatory PepT1-Mediated Tripeptide KPV in a Murine Model, examining kpv tripeptide demonstrates therapeutic benefits against colitis-associated cancer in murine models. Cited source and RUO context from RemedyX Labs.